Disclosed is a composition comprising a delta-PKC activator, an alpha-PKC inhibitor, and a pharmaceutically acceptable carrier that is free of Ca2+ and Mg2+ cations. The delta-PKC activator and the alpha-PKC inhibitor are as defined in the complete specification. The composition is used in the treatment of skin wounds.